Oriol Mirallas MD· @DrMirallas · X·· 2026-04-19Score60
Body
#AACR26
Educational session: chemistry to clinic, next-gen #ADC
Dr. Wang
Kinase inhibitors ADC #PI3K #HER2
New approach
Efficacy of #PI3K inhibitor #Comp3
Pertuzumab backbone
DAR 6
Completely new approach
Targeted therapy in #ADC
@OncoAlert
@AACR
Heat 13 · 8 likes · 0 replies · 5 reposts
Conference abstracts
6741matched by 药名 pertuzumab
Tertiary lymphoid structure (TLS)-associated immune circuits define response to durvalumab, trastuzumab, and pertuzumab (DTP) in HER2-enriched early breast cancerMailin Li, Xen Ping Hoi, Jenying Deng, Junjun Zheng, Rabia Hashmani, Recep Bayraktar, Wei Qian, Jianying Zhou, Jian Guan, Kai Sun, Hanh Mai, Tiffany Sheu, Susan Haley, Mary Schwartz, Sunil Mathur, Stephen T. Wong, Fotis Nikolo, Keith Syson Chan, Polly Niravath, Jenny C. Chang
Read the abstract →Source: Oriol Mirallas MD · x.com